Privacy Act of 1974; Report of an Altered System of Records
In accordance with the requirements of the Privacy Act of 1974, the Health Resources and Services Administration (HRSA) is publishing notice of a proposal to alter the system of records for Health Professions Planning and Evaluation (SORN 09-15-0046; 63FR14124).
Regional Collaborative for the Pacific Basin (RCPB) Cooperative Agreement
HRSA will be providing supplemental funds to support activities for a regional Pacific Primary Care Organization to represent the six U.S.-affiliated Pacific Basin jurisdictions. The supplemental funds will be used to augment the grantee's current
Notice of Availability of Final Policy Document
HRSA is publishing a Final Agency Guidance (``Policy Information Notice'' (PIN) 2010-01) to describe the documentation that will be considered by the Health Resources and Services Administration (HRSA) in confirming public agency status for organizations that self- identify as public agencies (also referred to in previous PINs as ``public entities'' or ``public applicants'') for Health Center Program grant funding authorized under section 330 of the Public Health Service Act, as amended, and/or for Federally Qualified Health Center Look- Alike designation. The PIN, ``Confirming Public Agency Status under the Health Center Program and FQHC Look-Alike Program,'' and the Agency's ``Response to Public Comments'' are available on the Internet at http:/ /bphc.hrsa.gov/policy/pin1001/and http://bphc.hrsa.gov/policy/pin1001/ PublcCommentsPIN2010-01.pdf, respectively.
Notice Regarding 340B Drug Pricing Program-Contract Pharmacy Services
Section 602 of Public Law 102-585, the ``Veterans Health Care Act of 1992'' enacted Section 340B of the Public Health Service Act (PHS). Section 340B implements a drug pricing program by which manufacturers who sell covered outpatient drugs to particular covered entities listed in the statute must agree to charge a price that will not exceed the amount determined under a statutory formula. The purpose of this Final Notice is to inform interested parties of final guidelines regarding the utilization of multiple contract pharmacies and suggested contract pharmacy provisions, which had been previously limited to the Alternative Methods Demonstration Project program.